
|Articles|March 1, 2003
Testing the Tablet
Vienna -- Oral pimecrolimus is an effective and well-tolerated treatment for certain inflammatory skin diseases, such as chronic plaque psoriasis and atopic dermatitis, according to Klaus Wolff, M.D., F.R.C.P., professor of dermatology and chairman, department of dermatology, University of Vienna, Austria.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















